Ensysce Biosciences, Inc.

Leisure Acquisition Corp., listed under the ticker LACQ, is a blank-check company that completed its initial public offering in 2019 with a stated focus on the leisure and entertainment industry. The vehicle filed an 8-K with the SEC on December 31, 2019, during its target search phase. LACQ subsequently entered into a definitive business combination with Ensysce Biosciences, Inc., a pharmaceutical company developing abuse-deterrent drug technologies, representing a marked sector pivot from the SPAC's original leisure mandate. The transaction closed and the combined entity now operates as Ensysce Biosciences. Sign up at SpacDesk for complete filing histories, deal timelines, and analytics across the full SPAC universe.